Search Results - "Chua, Melvin L.K"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy by Cai, Jinhua, Zheng, Junjiong, Shen, Jun, Yuan, Zhiyong, Xie, Mingwei, Gao, Miaomiao, Tan, Hongqi, Liang, Zhongguo, Rong, Xiaoming, Li, Yi, Li, Honghong, Jiang, Jingru, Zhao, Huiying, Argyriou, Andreas A, Chua, Melvin L K, Tang, Yamei

    Published in Clinical cancer research (15-10-2020)
    “…Bevacizumab is considered a promising therapy for brain necrosis after radiotherapy, while some patients fail to derive benefit or even worsen. Hence, we…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Multidisciplinary team meetings — challenges of implementation science by Iyer, N. Gopalakrishna, Chua, Melvin L. K.

    Published in Nature reviews. Clinical oncology (01-04-2019)
    “…Multidisciplinary team meetings have several flaws; herein, we propose approaches for cancer centres to transform these limitations into improvements in the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty by Huang, Luo, Chua, Melvin L.K.

    Published in Cancer communications (London, England) (01-03-2020)
    “…[...]to human papilloma virus-associated oropharyngeal squamous cell carcinoma, Epstein-Barr virus (EBV)-associated NPC is exquisitely sensitive to RT…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Targeting DNA Repair for Precision Radiotherapy – Balancing the Therapeutic Ratio by Mahamud, Osman, So, Jonathan, Chua, Melvin L.K, Bristow, Robert G

    Published in Current problems in cancer (01-07-2017)
    “…Abstract Genomic instability is underpinned by defects in the DNA damage response (DDR) and DNA repair pathways. Subsequent clonal selection and adaption can…”
    Get full text
    Journal Article
  13. 13

    Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors by Wu, Qiuji, Chu, Qian, Zhang, Hongyan, Yang, Bin, He, Xudong, Zhong, Yahua, Yuan, Xianglin, Chua, Melvin L.K., Xie, Conghua

    Published in Cancer communications (London, England) (01-08-2020)
    “…Abbreviations COVID-19 coronavirus disease 2019 CTLA-4 cytotoxic T-lymphocyte-associated protein 4 ICI immune checkpoint inhibitor IL-6 interleukin-6 PD-1…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis by Ng, Wai Tong, But, Barton, Wong, Charlene H.L., Choi, Cheuk-Wai, Chua, Melvin L.K., Blanchard, Pierre, Lee, Anne W.M.

    “…•Particle beam therapy yields excellent short-term treatment outcomes among NPC patients.•Particle beam therapy is generally safe in primary and recurrent NPC…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific by de Guzman, Roselle B, Chua, Melvin L K, Goldstein, David, Aung, Soe, Eaton, Vanessa, Park, Keunchil

    Published in JCO global oncology (01-02-2023)
    “…The demand for high-quality and more comprehensive oncology care will continue to rise globally. Effective leadership is particularly important. The evolving…”
    Get full text
    Journal Article
  19. 19
  20. 20